Systemic Inflammation-Related Bradycardia in COVID-19

  • Srinivasan A
  • Pansuriya T
  • Wilson B
  • et al.
N/ACitations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Systemic inflammation-related sinus bradycardia in COVID-19 infection has not been well described yet. This six-patient case series excludes common causes of bradycardia. As bradycardia may be a sequela of COVID-19 infection, we recommend closely monitoring hemodynamics and stopping medications that can exacerbate bradycardia in these patients.

Cite

CITATION STYLE

APA

Srinivasan, A., Pansuriya, T., Wilson, B., Sarva, S. T., Jayaram, T., Alim, S., … Raza, S. (2021). Systemic Inflammation-Related Bradycardia in COVID-19. Case Reports in Cardiology, 2021, 1–6. https://doi.org/10.1155/2021/9986955

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free